Capital Advisors Ltd’s Filana Therapeutics FLNA Stock Holding History

Capital Advisors Ltd’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$0	Buy	+4	New	+$6	﹤0.01%	1557
2025 Q2	–	Sell	-23	Closed	–	–	1602
2025 Q1	$0	Buy	+23	New	+$58	﹤0.01%	1555
2024 Q3	–	Sell	-309	Closed	-$4K	–	1583
2024 Q2	$4K	Hold	309	–	–	﹤0.01%	955
2024 Q1	$6K	Hold	309	–	–	﹤0.01%	852
2023 Q4	$7K	Hold	309	–	–	﹤0.01%	765
2023 Q3	$5K	Hold	309	–	–	﹤0.01%	836
2023 Q2	$8K	Buy	+309	New	+$7.44K	﹤0.01%	740
2023 Q1	–	Sell	-309	Closed	–	–	1512
2022 Q4	$0	Buy	+309	New	+$11.1K	﹤0.01%	1581

Other funds holding FLNA

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Capital Advisors Ltd's FLNA Position: Q2 2026 in Review

Capital Advisors Ltd opened a new position in Filana Therapeutics (FLNA) in Q2 2026: 4 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1557 among its holdings. This is a return to the name: Capital Advisors Ltd previously reported a position in FLNA as recently as Q1 2025.

Capital Advisors Ltd first reported a position in FLNA in Q4 2022 and has held it in 8 quarters since. The position peaked at $8K in Q2 2023. 85 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

Capital Advisors Ltd held 4 shares of Filana Therapeutics worth $0 as of Q2 2026.
Filana Therapeutics was a new Capital Advisors Ltd position in Q2 2026.
Filana Therapeutics made up ﹤0.01% of Capital Advisors Ltd's portfolio in Q2 2026, its #1557 holding.
Capital Advisors Ltd first reported a position in Filana Therapeutics in Q4 2022 and has held it in 8 quarters since.
Capital Advisors Ltd's Filana Therapeutics position peaked at $8K in Q2 2023.
85 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.